Chinatsu Makiyama

Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study

Toshikazu Moriwaki, Shota Fukuoka, Hiroya Taniguchi et al. · The Oncologist · 2017 · 104 citations · Full text

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer

Akitaka Makiyama, Kohei Arimizu, Gen Hirano et al. · Gastric Cancer · 2017 · 56 citations · Full text

Irinotecan Monotherapy, Surgical Oncology, Gastrointestinal Oncology +9

Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer

Kotoe Takayoshi, Hitoshi Kusaba, Masato Uenomachi et al. · Cancer Chemotherapy and Pharmacology · 2017 · 31 citations · Full text

Oncology, Gastrointestinal Oncology, Cancer Management +5

NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: a case report

Kohei Arimizu, Gen Hirano, Chinatsu Makiyama et al. · BMC Cancer · 2018 · 29 citations · Full text

Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.

Gen Hirano, Akitaka Makiyama, Chinatsu Makiyama et al. · PubMed · 2015 · 18 citations